Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Oral surgeons typically begin with conservative care for early jawbone exposure, or osteonecrosis of the jaw, rather than immediate surgery. Standard first-line treatment includes antimicrobial mouth rinses such as chlorhexidine, targeted antibiotics if infection is present, pain management, and careful monitoring of the exposed bone over time. Sharp bony edges may be gently smoothed, and loose bone fragments that separate on their own are removed, but healthy surrounding tissue is preserved. Surgeons also address contributing factors, coordinating with your medical team about medications like bisphosphonates or denosumab, managing diabetes, and encouraging tobacco cessation to support healing. There are several important details and staging considerations that affect which approach is right for you, so see below to understand more.
Consider taking a free, instant symptom check online to clarify what your symptoms may indicate and help you decide on timely next steps.
Last reviewed for medical accuracy: 08/18/2026
How Oral Surgeons Treat Early Jawbone Exposure: Important Conservative Care
Jawbone exposure in patients on bisphosphonates can be alarming, but early intervention often leads to good outcomes. When the condition is classified as Bisphosphonate related osteonecrosis stage 1, conservative management by an oral surgeon is the standard of care. This guide explains what you need to know about diagnosis, non-invasive treatments, and self-care strategies.
Bisphosphonates are medications commonly used to treat osteoporosis and certain cancers. A small percentage of patients develop osteonecrosis of the jaw (ONJ), where part of the jawbone is exposed through the gum. The American Association of Oral and Maxillofacial Surgeons (AAOMS) defines stage 1 as:
Early stage identification is crucial. At stage 1, conservative measures aim to control symptoms, maintain oral hygiene, and prevent progression to more severe stages.
When you see an oral surgeon for suspected early jawbone exposure, the evaluation typically includes:
Accurate staging as Bisphosphonate related osteonecrosis stage 1 treatment guides the conservative approach and helps avoid overtreatment.
The main goal of conservative care is to control local factors, alleviate discomfort, and prevent infection. Oral surgeons typically recommend:
Your active participation in conservative care is vital. Key self-care steps include:
Meticulous Oral Hygiene
• Soft-bristle toothbrush twice daily
• Interdental brushes or floss gently around exposed area
• Rinse after meals with water or saline
Dietary Adjustments
• Soft, non-abrasive foods (e.g., yogurt, mashed vegetables)
• Avoid hard, crunchy, or sharp foods that can injure the exposed bone
• Stay hydrated to promote tissue health
Avoid Smoking and Alcohol
• Both impair healing and increase risk of progression
• Seek support groups or smoking cessation programs if needed
Stress Management
• High stress can affect immunity and healing
• Activities like gentle yoga, meditation, or walks can help
Regular Dental Check-Ups
• Non-invasive cleanings every 3–4 months
• Immediate reporting of any new discomfort or swelling
Most patients with stage 1 disease improve with the above measures. However, if you notice any of the following, contact your oral surgeon promptly:
Progression to stage 2 (infection with clinical symptoms) or stage 3 (extensive necrosis, fracture, fistula) may require more aggressive interventions, including surgery, broader antibiotic therapy, or referral to a hospital setting.
Research into adjunctive treatments for Bisphosphonate related osteonecrosis stage 1 treatment is ongoing. Some options under investigation include:
These are not standard first-line treatments but may be considered on a case-by-case basis, especially in refractory cases or clinical trials.
Managing early jawbone exposure often involves coordination between:
This team approach ensures that your medications are reviewed, risk factors are optimized, and communication is clear across specialties.
If you’re experiencing any jaw discomfort, exposed bone, or unusual oral changes, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights and get tailored guidance before your next dental or medical appointment.
If you notice any worsening symptoms or signs of infection, speak to your oral surgeon right away. For anything life-threatening or serious, always seek immediate medical attention or call emergency services.
(References)
* Catterall A. Legg-Calvé-Perthes syndrome. Clin Orthop Relat Res. 1981 Jul-Aug;(158):41-52. PMID: 7023775.
* Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev. 2018 Sep;69:177-187. doi: 10.1016/j.ctrv.2018.06.007. Epub 2018 Jun 18. PMID: 30055439.
* Monteagudo M, Maceira E. Management of Müller-Weiss Disease. Foot Ankle Clin. 2019 Mar;24(1):89-105. doi: 10.1016/j.fcl.2018.09.006. PMID: 30685016.
* Cavalcante RC, Tomasetti G. Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review. J Craniomaxillofac Surg. 2020 Nov;48(11):1080-1086. doi: 10.1016/j.jcms.2020.09.008. Epub 2020 Sep 18. PMID: 32998853.
* Camus EJ, Van Overstraeten L. Kienböck's disease in 2021. Orthop Traumatol Surg Res. 2022 Feb;108(1S):103161. doi: 10.1016/j.otsr.2021.103161. Epub 2021 Nov 30. PMID: 34861414.
* Sokolow C, Bourcheix L. Preiser's disease. Hand Surg Rehabil. 2022 Oct;41(5):533-541. doi: 10.1016/j.hansur.2022.06.004. Epub 2022 Jul 5. PMID: 35803522.
* Roth A, Maus U. [Drug treatment of osteonecrosis]. Orthopadie (Heidelb). 2022 Oct;51(10):783-791. doi: 10.1007/s00132-022-04300-2. Epub 2022 Sep 8. PMID: 36074164.
* Goncharov EN, Koval OA, Nikolaevich Bezuglov E, Aleksandrovich Vetoshkin A, Gavriilovich Goncharov N, Encarnación Ramirez MJ, Montemurro N. Conservative Treatment in Avascular Necrosis of the Femoral Head: A Systematic Review. Med Sci (Basel). 2024 Jul 2;12(3). doi: 10.3390/medsci12030032. Epub 2024 Jul 2. PMID: 39051378; PMCID: PMC11270198.
* Wilczyński B, Taraszkiewicz M, de Tillier K, Biały M, Zorena K. Sinding-Larsen-Johansson disease. Clinical features, imaging findings, conservative treatments and research perspectives: a scoping review. PeerJ. 2024;12:e17996. doi: 10.7717/peerj.17996. Epub 2024 Sep 25. PMID: 39346060; PMCID: PMC11438430.
* Lang S, Maggen B. Müller-Weiss Disease. J Am Podiatr Med Assoc. 2025 Mar-Apr;115(2). doi: 10.7547/22-193. PMID: 40286309.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.